Description

Ethyl 2-((3-(2-Chlorophenyl)-5-Methylisoxazol-4-Yl)Carbonylamino)-4,5,6,7-Tetrahydrobenzo[B]Thiophene-3-Carboxylate is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure. This compound is critical for the synthesis of novel active pharmaceutical ingredients (APIs), offering researchers and manufacturers a reliable building block for drug discovery and development. It is primarily utilized by pharmaceutical R&D laboratories and fine chemical producers focused on creating new therapeutic agents, particularly in areas requiring sophisticated molecular architectures.

Application

• Pharmaceutical Intermediate: Serves as a key synthetic precursor in the research and production of new drug candidates.
• Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• API Synthesis: Integral in multi-step synthetic routes for the manufacture of target active pharmaceutical ingredients.
• Biochemical Tool Compound: May be employed in biochemical assays to study specific biological pathways or enzyme interactions.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for custom synthesis projects.
• Academic Research: Utilized in university and institutional labs for advanced organic synthesis and heterocyclic chemistry studies.

Basic Information

Product Name	Ethyl 2-((3-(2-Chlorophenyl)-5-Methylisoxazol-4-Yl)Carbonylamino)-4,5,6,7-Tetrahydrobenzo[B]Thiophene-3-Carboxylate
CAS No.	301680-88-6
Molecular Formula	C22H21ClN2O4S
Molecular Weight	444.93 g/mol
Synonyms	Ethyl 2-[[3-(2-chlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate; 4,5,6,7-Tetrahydrobenzo[b]thiophene-3-carboxylic acid, 2-[[[3-(2-chlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-, ethyl ester; 301680-88-6; UNII-9J2Q7I8C3P; 9J2Q7I8C3P; SCHEMBL118276; AKOS025147421; DB08299
EINECS	Contact for details

Quality Control

Every batch of Ethyl 2-((3-(2-Chlorophenyl)-5-Methylisoxazol-4-Yl)Carbonylamino)-4,5,6,7-Tetrahydrobenzo[B]Thiophene-3-Carboxylate is manufactured under strict quality management systems. Our products undergo rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency meet the exacting standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing all specifications is provided with each shipment to guarantee traceability and compliance.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). The container should be kept in a well-ventilated area and protected from moisture. For long-term storage, consider inert atmosphere conditions.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Any individual impurity ≤ 0.5%
Total Impurities	≤ 2.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Loss on Drying	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.